Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) on Mar. 3 announced the appointment of Mark P. Carthy to the company’s Board of Directors. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) stock opened at $1.30 in last session, and closed at $1.32, while the day range of Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) stock is $1.28 – $1.35. The stock showed a positive weekly performance of -2.22%.
CytRx Corporation (NASDAQ:CYTR) on Mar. 5 reported financial results for the 12 months ended December 31, 2013, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs. CytRx Corporation (NASDAQ:CYTR) stock opened at $5.61 in last session, and closed at $5.32 by losing -6.17%. The 52 week range of $1.95 – $8.35. Company’s market capitalization is $162.26 million.
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, announced that the Company expects to report fourth quarter and full year 2013 financial results after the market closes Wednesday, March 12, 2014. CEO, Jack Khattar, and CFO, Greg Patrick, will be hosting a conference call on Thursday, March 13, 2014 at 9:00 AM Eastern Time, to discuss 2013 financial results and to provide a business update. Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) stock decreased -5.75% and finished the last session at $9.18. The EPS of the stock remained -2.77. Company’s market capitalization is $284.04 million.
Goldman Sachs restated their neutral rating on shares of Ariad Pharmaceuticals (NASDAQ:ARIA) in a report issued on Thursday, StockRatingsNetwork reports. Ariad Pharmaceuticals (NASDAQ:ARIA) traded down 3.34% during mid-day trading on Thursday, hitting $8.69. 17,167,914 shares of the company’s stock traded hands. Ariad Pharmaceuticals has a 1-year low of $2.15 and a 1-year high of $23.00. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened the session at $8.41, and closed the session at $8.13. The 52 week range of the Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock remained $2.15 – $23.00 and the day range was $8.08 – $8.48.
Leave a Reply